|
|
||||||||
12,1412,14-prostaglandin J2 in Activated Human Astrocytes, But Not in Human Brain Macrophages1
Laboratory of Molecular Medicine and Neuroscience, National Institutes of Health, Bethesda, MD 20892
Overexpression of the inducible cyclooxygenase (COX-2) and
inducible NO synthase (iNOS) in activated brain macrophages (microglia)
and astrocytes appears central to many neuroinflammatory conditions.
15-Deoxy-
12,14-PGJ2 (15d-PGJ2)
is a ligand for the peroxisome proliferator-activated receptor
(PPAR)
. It has been proposed as an inhibitor of microglial
activation, based on the study of iNOS down-regulation in rodent
microglia. Because iNOS induction after cytokine activation remains
controversial in human microglia, we examined the effect of
15d-PGJ2 and other PPAR agonists on human microglia and
astrocytes, using COX-2 induction as an index of activation. We found
that PPAR
ligands (clofibrate and WY14643) enhanced IL-1
-induced
COX-2 expression in human astrocytes and microglia, while inhibiting
IL-1
plus IFN-
induction of iNOS in astrocytes. This is the first
description of an inhibition of iNOS uncoupled from that of COX-2.
15d-PGJ2 suppressed COX-2 induction in human astrocytes. It
prevented NF-
B binding to the COX-2 promoter through a new pathway
that is the repression of NF-
Bp50 induction by IL-1
. In contrast,
15d-PGJ2 increased c-Jun and c-Fos DNA-binding activity in
astrocytes, which may result in the activation of other inflammatory
pathways. In human microglia, no effect of 15d-PGJ2 on
COX-2 and NF-
Bp65/p50 induction was observed. However, the entry of
15d-PGJ2 occurred in microglia because STAT-1 and c-Jun
expression was modulated. Our data suggest the existence of novel
pathways mediated by 15d-PGJ2 in human astrocytes. They
also demonstrate that, unlike astrocytes and peripheral macrophages or
rodent brain macrophages, human microglia are not subject to the
anti-inflammatory effect of 15d-PGJ2 in terms of COX-2
inhibition.
This article has been cited by other articles:
![]() |
P. Mandin, F. Repoila, M. Vergassola, T. Geissmann, and P. Cossart Identification of new noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets Nucleic Acids Res., February 16, 2007; 35(3): 962 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Ackerman IV, X. L. Zhang, B. H. Rovin, and D. A. Kniss Modulation of Cytokine-Induced Cyclooxygenase 2 Expression by PPARG Ligands Through NF{kappa}B Signal Disruption in Human WISH and Amnion Cells Biol Reprod, September 1, 2005; 73(3): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M Lindstrom and P. R Bennett 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Interleukin-1{beta}-Induced Nuclear Factor-{kappa}B in Human Amnion and Myometrial Cells: Mechanisms and Implications J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3534 - 3543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hwang, D. J. Kleinhenz, B. Lassegue, K. K. Griendling, S. Dikalov, and C. M. Hart Peroxisome proliferator-activated receptor-{gamma} ligands regulate endothelial membrane superoxide production Am J Physiol Cell Physiol, April 1, 2005; 288(4): C899 - C905. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Si, M.-L. Zhao, A. C. A. Morgan, C. F. Brosnan, and S. C. Lee 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications J. Immunol., September 1, 2004; 173(5): 3504 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mouihate, L. Boisse, and Q. J. Pittman A Novel Antipyretic Action of 15-Deoxy-{Delta}12,14-Prostaglandin J2 in the Rat Brain J. Neurosci., February 11, 2004; 24(6): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Chen, Y.-H. Chang, C.-J. Tsi, and W.-W. Lin Inhibition of IFN-{gamma}-Mediated Inducible Nitric Oxide Synthase Induction by the Peroxisome Proliferator-Activated Receptor {gamma} Agonist, 15-Deoxy-{Delta}12,14-Prostaglandin J2, Involves Inhibition of the Upstream Janus Kinase/STAT1 Signaling Pathway J. Immunol., July 15, 2003; 171(2): 979 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |